Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanyang Liu

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Pharmacology|January 28, 2022
Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation PathwaysFei Zhou, Mingning Ding, Yiqing Gu, et al.
Cell Reports|January 6, 2021
Attenuation of Antiviral Immune Response Caused by Perturbation of TRIM25-Mediated RIG-I Activation under Simulated MicrogravityLvyun Zhu, Li Nie, Sisi Xie, et al.
Frontiers in Immunology|August 7, 2025
Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summaryYuanbin Huang, Xinmiao Ma, Hengxing Zhu, et al.
Frontiers in Immunology|December 17, 2024
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1Lvyun Zhu, Ying Qu, Junru Yang, et al.
Nature Communications|March 29, 2024
Photocobilins integrate B<sub>12</sub> and bilin photochemistry for enzyme controlShaowei Zhang, Laura N Jeffreys, Harshwardhan Poddar, et al.
Imeta|December 31, 2025
Genome-wide CRISPR screen reveals an uncharacterized spliceosome regulator as new candidate immunotherapy targetTong Shao, Chuanyang Liu, Jingyu Kuang, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Pharmacology|January 28, 2022
Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation PathwaysFei Zhou, Mingning Ding, Yiqing Gu, et al.
Cell Reports|January 6, 2021
Attenuation of Antiviral Immune Response Caused by Perturbation of TRIM25-Mediated RIG-I Activation under Simulated MicrogravityLvyun Zhu, Li Nie, Sisi Xie, et al.
Frontiers in Immunology|August 7, 2025
Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summaryYuanbin Huang, Xinmiao Ma, Hengxing Zhu, et al.
Frontiers in Immunology|December 17, 2024
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1Lvyun Zhu, Ying Qu, Junru Yang, et al.
Nature Communications|March 29, 2024
Photocobilins integrate B<sub>12</sub> and bilin photochemistry for enzyme controlShaowei Zhang, Laura N Jeffreys, Harshwardhan Poddar, et al.
Imeta|December 31, 2025
Genome-wide CRISPR screen reveals an uncharacterized spliceosome regulator as new candidate immunotherapy targetTong Shao, Chuanyang Liu, Jingyu Kuang, et al.
Pageof 5